Catalogo dei prodotti della ricerca

LEONARDI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.073
EU - Europa 1.196
AS - Asia 692
SA - Sud America 75
OC - Oceania 38
AF - Africa 35
Totale 4.109
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.040
IT - Italia 665
SG - Singapore 365
IN - India 108
CN - Cina 89
GB - Regno Unito 77
SE - Svezia 72
BR - Brasile 56
RU - Federazione Russa 52
DE - Germania 45
FI - Finlandia 38
AU - Australia 37
JP - Giappone 35
NL - Olanda 34
FR - Francia 30
KR - Corea 27
AT - Austria 25
CA - Canada 23
ID - Indonesia 23
IE - Irlanda 23
BE - Belgio 19
BG - Bulgaria 17
TG - Togo 17
RO - Romania 10
AR - Argentina 9
ES - Italia 9
HU - Ungheria 9
TR - Turchia 9
AL - Albania 8
CH - Svizzera 7
PL - Polonia 7
UA - Ucraina 7
VN - Vietnam 7
CZ - Repubblica Ceca 6
EC - Ecuador 6
EE - Estonia 6
IR - Iran 6
MA - Marocco 6
RS - Serbia 6
HK - Hong Kong 5
LI - Liechtenstein 5
PK - Pakistan 5
ZA - Sudafrica 5
BA - Bosnia-Erzegovina 4
MX - Messico 4
GL - Groenlandia 3
GR - Grecia 3
IL - Israele 3
LT - Lituania 3
SC - Seychelles 3
AE - Emirati Arabi Uniti 2
CO - Colombia 2
CR - Costa Rica 2
DK - Danimarca 2
HR - Croazia 2
IQ - Iraq 2
IS - Islanda 2
TN - Tunisia 2
BD - Bangladesh 1
BT - Bhutan 1
BY - Bielorussia 1
CL - Cile 1
DZ - Algeria 1
EG - Egitto 1
GE - Georgia 1
JM - Giamaica 1
JO - Giordania 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PT - Portogallo 1
SA - Arabia Saudita 1
UZ - Uzbekistan 1
Totale 4.109
Salva come PNG Salva come JPEG
Città #
Fairfield 286
Singapore 230
Rome 212
Ashburn 181
Chandler 178
Woodbridge 122
Houston 120
Seattle 116
Cambridge 103
Santa Clara 80
Milan 78
Wilmington 70
San Paolo di Civitate 59
Dearborn 57
Princeton 47
Lawrence 39
New York 35
Cosenza 32
Boston 25
San Diego 25
Ann Arbor 24
Jakarta 23
Jungnang-gu 21
Plano 21
Dublin 20
Beijing 19
Millbury 19
Lomé 17
Sofia 17
Vienna 17
Helsinki 16
Moscow 15
Melbourne 14
Sydney 14
Andover 13
Bengaluru 13
Boardman 13
Los Angeles 13
Norwalk 13
Fuzhou 12
Naples 12
Waanrode 12
Nuremberg 11
Toronto 11
London 10
Tokyo 10
Florence 8
Nanjing 8
Colorado Springs 7
Council Bluffs 7
Falkenstein 7
Fasano 7
Hefei 7
Paris 7
Plymouth 7
Ponzano Veneto 7
São Paulo 7
Brisbane 6
Chicago 6
Frankfurt am Main 6
Lappeenranta 6
Manchester 6
Bremen 5
Brussels 5
Budapest 5
Dallas 5
Edinburgh 5
Fremont 5
Hanoi 5
Nagoya 5
Palermo 5
San Mateo 5
Tirana 5
Carol Stream 4
Federal 4
Izmir 4
Kyoto 4
Madrid 4
Mannheim 4
Newark 4
Ottawa 4
Pisa 4
Quito 4
Stockholm 4
Tallinn 4
Turin 4
Yubileyny 4
Zurich 4
Alghero 3
Amsterdam 3
Birmingham 3
Bolzano Vicentino 3
Brasília 3
Brent 3
Brescia 3
Buffalo 3
Cascina 3
Changsha 3
Falls Church 3
Hong Kong 3
Totale 2.755
Salva come PNG Salva come JPEG
Nome #
Use of dynamic movement orthoses to improve gait stability and trunk control in ataxic patients 277
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT). a multicentre, randomised, placebo-controlled, phase 3 trial 172
Riluzole in patients with hereditary cerebellar ataxia. a randomised, double-blind, placebo-controlled trial 120
Early-onset optic neuropathy as initial clinical presentation in SPG7 113
Gait patterns in patients with hereditary spastic paraparesis 98
Cerebellum and neuropsychiatric disorders: Insights from ARSACS 97
A wearable proprioceptive stabilizer for rehabilitation of limb and gait ataxia in hereditary cerebellar ataxias. A pilot open-labeled study 97
Nerve high-resolution ultrasonography in peripheral nerve injuries associated with supracondylar humeral fractures in children 97
Pigmentary degenerative maculopathy as prominent phenotype in an Italian SPG56/CYP2U1 family 96
GIFT-1, a phase IIa clinical trial to test the safety and efficacy of IFNγ administration in FRDA patients 94
Longitudinal neurophysiological assessment of intramuscular type-A botulin toxin in healthy humans 94
Changes of clinical, neurophysiological and nerve ultrasound characteristics in CIDP over time: a 3-year follow-up 93
Spinocerebellar ataxia type 3 in Italy. time to change mind 92
'When atlastin meets spastin' 92
Acute optic neuropathy associated with a novel MFN2 mutation 91
Multifocal motor neuropathy following treatment with adalimumab for ulcerative colitis 90
Nerve high resolution ultrasonography in Tangier disease 89
Spinocerebellar ataxia type 10 in Peru: the missing link in the Amerindian origin of the disease 88
Local stability of the trunk in patients with degenerative cerebellar ataxia during walking 88
Widening the phenotypical spectrum of EGR2-related CMT: unusual phenotype for R409W mutation 87
Risk factors for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): antecedent events, lifestyle and dietary habits. Data from the Italian CIDP Database 83
Progression of gait ataxia in patients with degenerative cerebellar disorders. A 4-year follow-up study 83
Attrv in lazio-italy: A high-prevalence region in a non-endemic country 81
Electrophysiological abnormalities in iatrogenic botulism: Two case reports and review of the literature 76
Muscle involvement in myasthenia gravis: Expanding the clinical spectrum of Myasthenia-Myositis association from a large cohort of patients 75
Muscle MRI in immune-mediated necrotizing myopathy (IMNM). implications for clinical management and treatment strategies 71
Quantitative sensory testing and skin biopsy findings in late‐onset ATTRv pre‐symptomatic carriers: relationships with predicted time of disease onset (PADO) 71
Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trials 68
Sensory ataxia as a prominent clinical presentation in three families with mutations in CYP7B1 66
Skin biopsy and quantitative sensory assessment in an Italian cohort of ATTRv patients with polyneuropathy and asymptomatic carriers: possible evidence of early non-length dependent denervation 66
Novel ACTA1 mutation causes late-presenting nemaline myopathy with unusual dark cores 64
Gender effect on cardiac involvement in myotonic dystrophy type 1 64
Comparison of quantitative muscle ultrasound and whole-body muscle MRI in facioscapulohumeral muscular dystrophy type 1 patients 58
Chronic inflammatory demyelinating polyradiculoneuropathy: can we make a diagnosis in patients not fulfilling electrodiagnostic criteria? 57
Impact of environmental factors and physical activity on disability and quality of life in CIDP 56
ATTRv amyloidosis Italian Registry: clinical and epidemiological data 56
Functional and morphometric assessment of small-fibre damage in late-onset hereditary transthyretin amyloidosis with polyneuropathy: the controversial relation between small-fibre-related symptoms and diagnostic test findings 54
null 53
High-resolution ultrasound of peripheral nerves in late-onset hereditary transthyretin amyloidosis with polyneuropathy: similarities and differences with CIDP 52
Muscle MRI as a biomarker of disease activity and progression in myotonic dystrophy type 1: a longitudinal study 49
Unclassified clinical presentations of chronic inflammatory demyelinating polyradiculoneuropathy 48
Distal upper limb involvement in myasthenia-myositis association 46
The neurophysiological lesson from the Italian CIDP database 46
Nerve ultrasonography findings as possible pitfall in differential diagnosis between hereditary transthyretin amyloidosis with polyneuropathy and chronic inflammatory demyelinating polyneuropathy 45
Serum neurofilament light chain levels correlate with small fiber related parameters in patients with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN) 44
Psychosocial burden and professional and social support in patients with hereditary transthyretin amyloidosis (ATTRv) and their relatives in Italy 43
Prolonged distal motor latency of median nerve does not improve diagnostic accuracy for CIDP 43
Real-life experience with inotersen in hereditary transthyretin amyloidosis with late-onset phenotype: data from an early- access program in Italy 43
Relevance of diagnostic investigations in chronic inflammatory demyelinating poliradiculoneuropathy. Data from the Italian CIDP database 42
Risk of disease relapse, safety and tolerability of SARS-CoV-2 vaccination in patients with chronic inflammatory neuropathies 41
Neuropathic pain experience in symptomatic and presymptomatic subjects carrying a transthyretin gene mutation 41
Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy 41
Prominent mitochondrial pathology in a case of refractory dermatomyositis: coincidence or concause? 41
Nerve high-resolution ultrasound in a 2-years follow-up of radial nerve palsy related to humeral shaft fractures 34
Eculizumab for myasthenic exacerbation during treatment with immune-checkpoint inhibitors 33
Skin amyloid deposits and nerve fiber loss as markers of neuropathy onset and progression in hereditary transthyretin amyloidosis 33
Impact of 2021 European Academy of Neurology/Peripheral Nerve Society diagnostic criteria on diagnosis and therapy of chronic inflammatory demyelinating polyradiculoneuropathy variants 31
Muscle hypertrophy following acquired neurogenic injury: systematic review and analysis of existing literature 31
Italian Real-Life Experience of Patients with Hereditary Transthyretin Amyloidosis Treated with Patisiran 29
Assessment of diagnostic criteria for multifocal motor neuropathy in patients included in the Italian database 27
De novo mutations in SPG3A: a challenge in differential diagnosis and genetic counselling 23
Serum neurofilament light chain: a promising early diagnostic biomarker for hereditary transthyretin amyloidosis? 21
Detailed clinical, physiological and pathological phenotyping can impact access to disease-modifying treatments in ATTR carriers 15
Exploring Cardiac Sympathetic Denervation in Transthyretin-Mediated Hereditary Amyloidosis (ATTRv): Insights from 123I-mIBG Scintigraphy 14
Long-term treatment of hereditary transthyretin amyloidosis with patisiran: multicentre, real-world experience in Italy 13
Patisiran in ATTRv amyloidosis with polyneuropathy: "PatisiranItaly" multicenter observational study 7
null 4
Safety and efficacy of chronic weekly rozanolixizumab in generalized myasthenia gravis: the randomized open-label extension MG0004 study 4
Minimal invasive biopsies are highly sensitive for amyloid detection in hereditary transthyretin amyloidosis with polyneuropathy 2
Peripherin, A New Promising Biomarker in Neurological Disorders 1
Totale 4.354
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.849
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.849
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020130 0 0 0 0 0 0 0 0 53 31 23 23
2020/2021280 17 22 10 29 16 10 19 15 32 55 29 26
2021/2022632 64 25 45 30 73 26 24 48 39 29 143 86
2022/2023758 96 136 18 86 90 85 30 47 72 25 49 24
2023/2024685 21 57 25 44 42 85 61 72 19 100 89 70
2024/20251.082 49 172 92 86 114 119 80 110 260 0 0 0
Totale 4.354